REDCARE PHARMACY NV (RDC.DE) Stock Income Statement
FRA:RDC - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.53B | 2.37B | 1.80B | 1.20B | 1.06B | |||
| Minority Interest Expense | 1.31M | 892.00K | -435.00K | N/A | N/A | |||
| Cost Of Goods | 1.95B | 1.82B | 1.36B | 872.60M | 793.80M | |||
| Gross Profit | 582.18M | 545.78M | 440.38M | 331.80M | 266.50M | |||
| Operating Expenses | 623.34M | 584.22M | 448.00M | 385.20M | 332.40M | |||
| Selling, General, and Administrative Expenses | 623.94M | 516.00M | 390.71M | 345.80M | 305.50M | |||
| Operating Income | -41.15M | -38.44M | -7.62M | -53.50M | -65.90M | |||
| Interest Income/Expense | -9.33M | -439.00K | -2.89M | -7.70M | -5.80M | |||
| Other Income/Expense | N/A | -8.41M | 5.84M | -7.20M | -6.30M | |||
| Non Recurring Items | -1.23M | -548.00K | -9.68M | -15.70M | 200.00K | |||
| Income Before Taxes | -51.71M | -47.83M | -14.35M | -84.10M | -77.90M | |||
| Income Tax | -1.92M | -1.48M | -2.74M | -6.50M | -3.70M | |||
| Net Income | -48.48M | -45.46M | -12.04M | -77.60M | -74.20M | |||
| EBITDA | 27.58M | 29.78M | 49.67M | -13.99M | -38.94M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.46 | -2.27 | -0.63 | -4.32 | -4.15 | |||
| Non GAAP EPS | -2.41 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 23.03% | 23.02% | 24.48% | 27.55% | 25.13% | |||
| Profit Margin | -1.92% | -1.92% | -0.67% | -6.44% | -7.00% | |||
| Operating Profit Margin | -1.63% | -1.62% | -0.42% | -4.44% | -6.22% | |||
All data in EUR